Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 4, 2003, Pages 177-182

  Hanyu, Haruo ^a   Shimizu, Takeshi ^a   Tanaka, Yuriko ^a   Takasaki, Masaru ^a   Koizumi, Kiyoshi ^a   Abe, Kimihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Donepezil; Frontal lobe; Regional cerebral blood flow; Single photon emission computed tomography

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; SURFACE PROPERTY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDANS; MALE; MIDDLE AGED; PIPERIDINES; PSYCHIATRIC STATUS RATING SCALES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0037221155     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068785     Document Type: Article

References (28)

1. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT: A 24-week, double-blind, placebo-controlled trial of Aricept in patients with Alzheimer's disease. Neurology 1998;50:136-145.
2. Giacobini E: Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer's disease. Alzheimer Dis Assoc Disord 2000;14 (suppl 1): S3-S10.
3. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A: The schintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-185.
4. 99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994;57:285-295.
5. Mann UM, Mohr E, Gearing M, Chase TN: Heterogeneity in Alzheimer's disease: Progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry 1992;55:956-959.
6. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
7. Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mosch D, Schad D, Schwaiger M, Kurz A: Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 1997;38:1095-1101.
8. Hirsch C, Bartenstein P, Minoshima S, Mosch D, Willoch F, Buch K, Schad D, Schwaiger M, Kurz A: Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer's disease: Evaluation of an observer-independent analytic approach. Dement Geriatr Cogn Disord 1997;8:98-104.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
10. Folstein MF, Folstein SE, McHugh PR: Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
12. Sands LP, Kats I, Schneider L: Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors. Alzheimer Dis Assoc Disord 1999;13:26-33.
13. Talairach J, Tournoux P: Co-planar stereotactic atlas of the human brain. New York, Thieme, 1998.
14. Minoshima S, Koeppe RA, Frey KA, Kuhl DE: Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
15. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-1109.
16. Hanyu H, Abe S, Arai H, Asano T, Iwamoto T, Takasaki M: Diagnostic accuracy of single photon emission computed tomography in Alzheimer's disease. Gerontology 1993;39:260-266.
17. Riekkinen P Jr, Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P Sr: Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease. Neuroreport 1997;8:1845-1849.
18. Mega MS, Dinov ID, Lee L, O'Connor SM, Masterman DM, Wilen B, Mishkin F, Toga AW, Cummings JL: Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2000;12:209-218.
19. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL: The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease. Arch Neurol 1999;56:1388-1393.
20. Muir JL, Everitt BJ, Robbins TW: AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function. J Neurosci 1994;14:2313-2326.
21. Voyko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL: Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 1994;14:167-186.
22. Warburton DM, Rusted JM: Cholinergic control of cognitive resources. Neuropsychobiology 1993;28:43-46.
23. 3 receptor antagonist, ondansetron. Psychopharmacology (Berl) 1995;118:82-92.
24. Vidal C: Nicotinic potentination of glutaminergic synapses in the prefrontal cortex: New insight into the analysis of the role of nicotinic receptors in cognitive functions. Drug Dev Res 1994;31:120-126.
25. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R: Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: Assessment of attentional and mnemonic function using CANTAB. Psychopharmacology (Berl) 1993;110:395-401.
26. Hunter R, Wyper DJ, Patterson J, Hansen MT, Goodwin GM: Cerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerized tomography. Br J Psychiatry 1991;158:351-357.
27. Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A: Changes in the rCBF images of patients with Alzheimer's disease receiving donepezil therapy. Nucl Med Commun 2000;21:37-41.
28. Scremin OU, Li MG, Scremin AM, Jenden DJ: Cholinesterase inhibition improves blood flow in ischemic cerebral cortex. Brain Res Bull 1997;42:59-70.